Patents by Inventor Bruce Alan FIRESTONE

Bruce Alan FIRESTONE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEGRADANT COMPOUND IN A MEDICAMENT
    Publication number: 20260256777
    Abstract: The present disclosure is directed to ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities, processes for preparing ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities, and methods of treating presbyopia and other ophthalmic conditions by administering ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities.
    Type: Application
    Filed: January 16, 2026
    Publication date: September 3, 2026
    Inventors: Rhett Mead SCHIFFMAN, Bruce Alan FIRESTONE
  • DEGRADANT COMPOUND IN A MEDICAMENT
    Publication number: 20240100046
    Abstract: The present disclosure is directed to ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities, processes for preparing ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities, and methods of treating presbyopia and other ophthalmic conditions by administering ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities.
    Type: Application
    Filed: December 11, 2023
    Publication date: March 28, 2024
    Inventors: Rhett Mead SCHIFFMAN, Bruce Alan FIRESTONE
  • DEGRADANT COMPOUND IN A MEDICANT
    Publication number: 20230390284
    Abstract: The present disclosure is directed to ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities, processes for preparing ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities, and methods of treating presbyopia and other ophthalmic conditions by administering ophthalmic formulations comprising carbachol, brimonidine, and less than 5% of one or more impurities.
    Type: Application
    Filed: November 2, 2021
    Publication date: December 7, 2023
    Inventors: Rhett Mead SCHIFFMAN, Bruce Alan FIRESTONE